EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical course of congestive hepatopathy pre/post heart transplantation

Lorenz Balcar, Georg Semmler, Bernhard Scheiner, Albert Friedrich Stättermayer, Stefan Ćosić, Philipp Schwabl, Niema Kazem, Mattias Mandorfer, Martin Hülsmann, Andreas Zuckermann, Thomas Reiberger

Wiener klinische Wochenschrift · 2024

DOI: 10.1007/s00508-023-02231-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiener klinische Wochenschrift, 2024. Verfasst von Lorenz Balcar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienn…. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Failure, Liver Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Heart failure (HF) might lead to increased hepatic venous pressure, thereby impairing hepatic blood outflow and subsequently inducing congestive hepatopathy. We aimed to evaluate prevalence of congestive hepatopathy in patients undergoing heart transplantation (HTX) as well as their post-transplant course.

Methods

Patients undergoing HTX from 2015–2020 at the Vienna General Hospital were included ( n = 205). Congestive hepatopathy was defined by hepatic congestion on abdominal imaging and hepatic injury. Laboratory parameters, ascites severity, and clinical events were assessed and post-HTX outcomes evaluated.

Results

At listing, 104 (54%) patients showed hepatic congestion, 97 (47%) hepatic injury, and 50 (26%) had ascites. Congestive hepatopathy was diagnosed in 60 (29%) patients, who showed more often ascites, lower serum sodium and cholinesterase activity, and higher hepatic injury markers. Mean albumin-bilirubin (ALBI)-score as well as (modified)-model for end-stage liver disease (MELD)-scores were higher in patients with congestive hepatopathy. Median levels of laboratory parameters/scores normalised after HTX, and ascites resolved in most patients with congestive hepatopathy ( n = 48/56, 86%). The post-HTX (median follow-up 55.1 months) survival was 87% and liver-related events were rare (3%). Severe ascites, low cholinesterase, and MELD/MELD-XI were associated with ascites persistence/death 1‑year after HTX. Age, male sex, and severe ascites were the only independent predictors of post-HTX mortality. Both ALBI and MELD-scores were robust indicators of post-HTX survival when measured 4 weeks after HTX (ALBI log-rank test p < 0.001; MELD log-rank test p = 0.012).

Conclusion

Congestive hepatopathy and ascites were mostly reversible after HTX. Liver-related scores and ascites improve prognostication in patients after HTX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationHeart FailureLiver DiseasesHumansMaleFemaleMiddle AgedAustriaAdultAscitesAgedPostoperative ComplicationsPrevalenceComorbidityTreatment OutcomeSurvival Rate

Stichwörter der Autor:innen

Cardiac cirrhosisCirrhosisCongestive hepatopathyHTXIschemic hepatitis

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Christian-Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
  • Department of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. thomas.reiberger@meduniwien.ac.at.

Förderung

  • Medical University of Vienna

Zitieren

APA

Balcar, L., Semmler, G., Scheiner, B., Stättermayer, A. F., Ćosić, S., Schwabl, P., Kazem, N., Mandorfer, M., Hülsmann, M., Zuckermann, A., & Reiberger, T. (2024). Clinical course of congestive hepatopathy pre/post heart transplantation. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-023-02231-2

Vancouver

Balcar L, Semmler G, Scheiner B, Stättermayer AF, Ćosić S, Schwabl P, et al. Clinical course of congestive hepatopathy pre/post heart transplantation. Wiener klinische Wochenschrift. 2024. doi:10.1007/s00508-023-02231-2

BibTeX
@article{Balcar2024,
  author = {Balcar, Lorenz and Semmler, Georg and Scheiner, Bernhard and Stättermayer, Albert Friedrich and Ćosić, Stefan and Schwabl, Philipp and Kazem, Niema and Mandorfer, Mattias and Hülsmann, Martin and Zuckermann, Andreas and Reiberger, Thomas},
  title = {Clinical course of congestive hepatopathy pre/post heart transplantation},
  journal = {Wiener klinische Wochenschrift},
  year = {2024},
  doi = {10.1007/s00508-023-02231-2}
}
Kostenlos starten →